Navigation Links
Self-Sterilizing Surfaces Technology Using Photodisinfection Recognized at EuCheMS Conference
Date:9/17/2013

(PRWEB) September 17, 2013

Ondine is pleased to announce that Sacha Noimark, Elaine Allan and Ivan Parkin were presented with the ‘Best Poster’ recognition at the EuCheMS Inorganic Chemistry Conference 2, Jerusalem 2013. The University College London group’s abstract entitled "Self Sterilizing Surfaces" introduces a novel technology and approach to decolonizing surface materials of pathogens involved in Healthcare Associated Infections (HAI’s). HAI’s present an enormous financial burden to the global healthcare system and are a significant source of patient morbidity and mortality.

The abstract describes the successful outcomes from the application of Photodisinfection (also known as antimicrobial Photodynamic Therapy) to decolonization of pathogens on material surfaces, such as those found in catheters, mobile phone or tablet covers, keyboards, paints etc. The work involved collaboration between the Materials Chemistry Research Centre, Department of Chemistry and the Division of Microbial Diseases both at the University College London (UCL), England and Ondine Biomedical Inc., Vancouver, B.C.

The development of resistance is causing antibiotics to become increasingly ineffective, pointing to the need for new infection-prevention strategies. The team at University College London developed the novel technology by embedding two photosensitizers into silicone urinary catheters, along with nanogold particles to enhance the photobactericidal effect. Bacteria that colonize the skin, such as Staphylococcus epidermidis, are often responsible for chronic infections of catheters that pass through or are in contact with the skin surface. The UCL team demonstrated that these bacteria were completely eliminated from the surface of the catheters – a reduction of over 1 million fold. This exciting development, achieved with only low levels of light, points the way to simple and inexpensive self-sterilizing catheters and potentially other surfaces commonly found in healthcare settings.

Photodisinfection was invented by Professor Michael Wilson at the Eastman Dental Institute, University College London in the 1980’s. UCL is the research partner of Ondine Biomedical Inc., the global leader in developing Photodisinfection (aPDT) based technologies and applications. Ondine is focused on Health Care Associated Infection (HAI) prevention products as well as therapies such as the MRSAid Photodisinfection System. For more information about Ondine, please visit http://www.ondinebio.com

Read the full story at http://www.prweb.com/releases/Ondine_MRSAid/Photodisinfection/prweb11130133.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Copper surfaces reduce the rate of health care-acquired infections in the ICU
2. UCLA study to determine if copper surfaces can reduce hospital-acquired infections
3. Phoseon Technology Opens New Office in the United Kingdom
4. BCC Research Publishes a New Report on Separation Systems for Commercial Biotechnology Markets
5. Gadgets Made Simple Investigates The Technology Behind AMG Services Bolting Solutions
6. Electronic whisper: Disney Research technology transmits audio messages via fingers touch
7. Biometrics Technology Market (Biometric Devices, Biometric Products, Biometric Fingerprint Equipment) Worth $11,229.3 Million in 2015 - New Report by MarketsandMarkets
8. Nobles Medical Technologies II Receives US Patent for “Suturing and Method” for its NobleStitch Technology
9. iTriage CEO and Co-founder, Dr. Peter Hudson, Receives “Entrepreneur of the Year” Award from Colorado Technology Association
10. Neuromodulation Market By (Procedure, Technology and Application) Worth $6.8 Billion - 2017 – New Report by Marketsandmarkets
11. Image Sensors Market By (Verticals, Applications, Technology & Geography) worth $10.75 Billion - 2018 – New Report by Marketsandmarkets
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/21/2017)... ... September 21, 2017 , ... SABRE is raising awareness about personal ... to the end of November. , The Chicago, Illinois, based self-defense brand has been ... them about the ease of taking their personal safety into their own hands. , ...
(Date:9/21/2017)... ... September 21, 2017 , ... Promotional ... http://www.fdanews.com/products/54818-promotional-communication      , In the competitive world of drug and device marketing ... in compliance with FDA rules. , The FDA has issued two draft guidances ...
(Date:9/21/2017)... ... September 21, 2017 , ... Demonstrating a consistent and continued ... have been awarded five-year accreditation status through the Public Health Accreditation Board ... by a PHAB-accredited health department now extend to more than 203 million ...
(Date:9/21/2017)... ... September 21, 2017 , ... In addition to sticking with ... more holistic approach and use natural alternatives for all house cleaning products, disinfectants, ... USDA guaranteeing that, the new line of essential oils, are all 100% organic ...
(Date:9/21/2017)... ... 2017 , ... The New England Center for Children® (NECC®), a global leader ... Hung to the Board of Directors. , “The New England Center for Children ... an invaluable addition to our team,” said Vincent Strully, Jr., President and CEO of ...
Breaking Medicine News(10 mins):
(Date:9/13/2017)... Sept. 13, 2017   OrthoAtlanta has been named ... Football Host Committee (AFHC) for the 2018 College Football Playoff ... 2018, at Mercedes-Benz Stadium in Atlanta, Georgia ... AFHC "I,m In" campaign, participating in many activities leading up ... ...
(Date:9/12/2017)... , Sept. 12, 2017  ValGenesis Inc., ... Solutions (VLMS), is pleased to announce the appointment ... member of its Board of Directors and Chairman ... VLMS enables life science companies to manage their ... use of paper in this process. Furthermore, ValGenesis ...
(Date:9/9/2017)...  Eli Lilly and Company (NYSE: LLY ... for lasmiditan, an investigational, oral, first-in-class molecule for the ... compared to placebo in the Phase 3 SPARTAN study. ... Congress of the International Headache Society (IHC) in ... today demonstrate lasmiditan,s potential to reduce pain and provide ...
Breaking Medicine Technology: